ArticleJournal of cancer survivorship : research and practice2025
Predictors of long-term follow-up clinic attendance and continued engagement among survivors of cancer in childhood and adolescence.
Article in Journal of cancer survivorship : research and practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Transition outcomes in a diverse cohort of higher-risk young adult survivors of childhood cancer in an established care model.Journal of cancer survivorship : research and practice · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
purposeSurvivorship care is vital to screen for and manage late effects, yet follow-up remains suboptimal. We examined factors associated with long-term survivor clinic (LTSC) nonattendance, delayed initiation, and disengagement at a large, diverse pediatric cancer center.
methodsWe analyzed outcomes in 1138 survivorship-eligible childhood cancer survivors diagnosed between 2011 and 2019. Outcomes included (1) LTSC nonattendance (no visit ≥ 2 years post-treatment), (2) delayed LTSC visit initiation (first visit > 5 years from end of treatment), and (3) LTSC visit disengagement (no follow-up after initial LTSC visit). Adjusted odds ratios (aORs) and 95% confidence intervals (CIs) for factors associated with each outcome were estimated by multivariable logistic regression.
resultsThe mean age at the end of treatment was 9.3 years (standard deviation ± 5.6); 56% were male, 50% Latino, and 42% had leukemia. Twenty-one percent never attended LTSC. Nonattendance was associated with older age (aOR = 1.15; 95% CI, 1.11-1.18), public (aOR = 2.37; 95% CI, 1.65-3.44), or no insurance (aOR = 2.58; 95% CI, 1.20-5.42). Delayed initiation was linked to higher odds of disengagement (aOR = 1.28; 95% CI, 0.85-1.92). Disengagement was higher among older (aOR = 1.09; 95% CI, 1.05-1.12) and publicly insured (aOR = 2.29; 95% CI, 1.55-3.42) survivors.
conclusionsTimely and accessible survivorship care is essential to mitigating late effects of cancer treatment. Here, one in five survivors did not receive survivorship care and patients that initiated LTSC early were more likely to remain engaged. Implications for Cancer Survivors Tailored interventions that support older and under-insured survivors and early referral to LTSC may improve survivor initiation and long-term engagement with survivorship care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.